These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27271289)

  • 1. Malignant transformation of low-grade gliomas in patients undergoing adjuvant therapy.
    Rotta JM; de Oliveira MF; Reis RC; Botelho RV
    Acta Neurol Belg; 2017 Mar; 117(1):235-239. PubMed ID: 27271289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
    Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.
    Broniscer A; Baker SJ; West AN; Fraser MM; Proko E; Kocak M; Dalton J; Zambetti GP; Ellison DW; Kun LE; Gajjar A; Gilbertson RJ; Fuller CE
    J Clin Oncol; 2007 Feb; 25(6):682-9. PubMed ID: 17308273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas.
    Sherman JH; Moldovan K; Yeoh HK; Starke RM; Pouratian N; Shaffrey ME; Schiff D
    J Neurosurg; 2011 Jun; 114(6):1617-21. PubMed ID: 21235313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
    Yordanova YN; Moritz-Gasser S; Duffau H
    J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 9. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
    Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
    Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
    Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of palliative treatment with temozolomide in patients with high-grade gliomas.
    Ziobro M; Rolski J; Grela-Wojewoda A; Zygulska A; Niemiec M
    Neurol Neurochir Pol; 2008; 42(3):210-5. PubMed ID: 18651326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
    Freyschlag CF; Smolczyk DR; Janzen E; Schmieder K; Thomé C; Lohr F; Wenz F; Weiss C; Tuettenberg J; Seiz M
    Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
    Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
    Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide.
    Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R
    Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
    Schiff D; Desjardins A; Cloughesy T; Mikkelsen T; Glantz M; Chamberlain MC; Reardon DA; Wen PY
    Cancer; 2016 Feb; 122(4):582-7. PubMed ID: 26588662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas.
    Valle G; Carmignani M; Brunetti L; Volpe AR
    J BUON; 2011; 16(4):787; author reply 787-8. PubMed ID: 22331745
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk Factors for Malignant Transformation of Low-Grade Glioma.
    Murphy ES; Leyrer CM; Parsons M; Suh JH; Chao ST; Yu JS; Kotecha R; Jia X; Peereboom DM; Prayson RA; Stevens GHJ; Barnett GH; Vogelbaum MA; Ahluwalia MS
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):965-971. PubMed ID: 29485076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas.
    Soritau O; Tomuleasa C; Aldea M; Petrushev B; Susman S; Gheban D; Ioani H; Cosis A; Brie I; Irimie A; Kacso G; Florian IS
    J BUON; 2011; 16(2):282-9. PubMed ID: 21766499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.